Onconetix implements 1-for-5 reverse stock split to maintain Nasdaq compliance

Onconetix, Inc.

• Reverse stock split effective March 25, 2026 at 12:01 a.m. Eastern Time.
• Ratio fixed at 1-for-5, reducing outstanding shares from ~3.6M to ~0.7M.
• No fractional shares issued; cash compensation based on March 24 closing price.
• CUSIP changes to 68237Q 302; stock trades under symbol ONCO on Nasdaq.
• Split intended to meet Nasdaq's $1.00 minimum bid price listing requirement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.